vimarsana.com
  1. Home
  2. Live Updates
  3. Pharma Investor Relations - Breaking News

Latest Breaking News On - Pharma investor relations - Page 4 : vimarsana.com

Royalty Pharma (RPRX) to Purchase Up to $1 5B of PTC Therapeutics Royalty on Evrysdi

Royalty Pharma (RPRX) to Purchase Up to $1 5B of PTC Therapeutics Royalty on Evrysdi
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesWilmer cutler pickering haleRoche evrysdiJohnson tremfyaNovarti promactaMatthew kleinJohnson imbruvicaPablo legorretaDrug administrationTherapeutics incGoodwin procterMuscular atrophy foundationExchange commissionRoyalty pharmaChief executive officerSpinal muscular atrophy foundation

Royalty Pharma Declares Fourth Quarter 2023 Dividend

Royalty Pharma Declares Fourth Quarter 2023 Dividend
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Johnson imbruvicaJohnson tremfyaNovarti promactaRoche evrysdiRoyalty pharmaPharma investor relations

Royalty Pharma Declares Fourth Quarter 2023 Dividend

NEW YORK, Oct. 16, 2023 The board of directors of Royalty Pharma plc has approved the payment of a dividend for the fourth quarter of 2023 of $0.20 per Class A ordinary share. The dividend.

Johnson imbruvicaNovarti promactaRoche evrysdiJohnson tremfyaRoyalty pharmaPharma investor relations

Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023

Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Johnson tremfyaJohnson imbruvicaNovarti promactaRoche evrysdiRoyalty pharmaPharma investor relations

Royalty Pharma Appoints Eric Schneider as Chief Technology Officer

NEW YORK, Sept. 21, 2023 Royalty Pharma plc today announced the appointment of Eric Schneider as Senior Vice President, Chief Technology Officer. Eric will also join Royalty Pharma’s Senior.

United statesPablo legorretaEric schneiderJohnson tremfyaNovarti promactaRoche evrysdiJohnson imbruvicaLeadership teamMoody investor servicesData strategy teamMckinsey companyExchange commissionRoyalty pharma senior leadership committeeTechnology officerSenior vice presidentChief technology

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.